HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

8th Edition of World Congress on Infectious Diseases

June 09-11, 2025 | Rome, Italy

June 09 -11, 2025 | Rome, Italy

Infection 2025

Speaker at Infectious Diseases Conferences - Francis J. Castellino
Keynote Presentation (In-Person)
Francis J. Castellino, University of Notre Dame, United States

The human innate immune system plays a central role in controlling the virulence of Streptococcal pyogenes (GAS) infections.  Important participants of the humoral response to these infections are the coagulation, complement, and inflammatory systems.  GAS responds to h [....] » Read More

Speaker at Infection Conference - Ronald Desrosiers
Keynote Presentation (In-Person)
Ronald Desrosiers, University of Miami Miller School of Medicine, United States

Antibody-based approaches for the treatment or prevention AIDS virus infection are made possible by an incredible array of monoclonal antibodies (mAbs) with potent neutralizing activity against a broad range of HIV isolates. Most infected people do not make such antibodies but we [....] » Read More

Speaker at Infectious Diseases Conferences - Claudia Ferreira
Keynote Presentation (In-Person)
Claudia Ferreira, Biophytis Sorbonne, France

A pandemic is considered as an outbreak of a disease occurring over a wide geographic area, crossing national borders, and affecting a high proportion of the world. During the 1st millennium AD, three main pandemics emerged. The Antonine Plague (165-190 AD), caused by hemorrhagic [....] » Read More

Speaker at Infection Conferences - Pio Conti
Keynote Presentation (In-Person)
Pio Conti, University in Chieti, Italy

Mast cells (MCs) originate from CD34+/CD117+/CD13+ pluripotent hematopoietic stem cells and they express the c-Kit receptor (c-Kit-R) which regulates their proliferation and sustains their survival, differentiation, and maturation. MCs are immune tissue cells derived from bone ma [....] » Read More

Speaker at Infection Conferences - Dong H Kwon
Oral Presentation (In-Person)
Dong H Kwon, Long Island University, United States

Infections with antibiotic resistance are associated with millions of deaths annually and are a significant healthcare challenge. A new antibiotic or strategy is an urgent priority to reduce antibiotic resistance. Glutathione (GSH) is a biogenic thiol compound for an optimal intr [....] » Read More

Speaker at Infectious Diseases Conferences - Carlo Ferrazzano
Oral Presentation (In-Person)
Carlo Ferrazzano, The University of Manchester, United Kingdom

Human papilloma virus (HPV) types 16 and 18 are the most common cause of cervical cancer where integration-associated loss-of-function of the viral E2 protein promotes malignant progression. HPV type 53 is a low-risk virus which does not promote malignant changes and the current [....] » Read More

Speaker at Infectious Diseases Conferences - Fernando Rubinstein
Oral Presentation (In-Person)
Fernando Rubinstein, Instituto de Efectividad Clinica y Sanitaria, Argentina

Introduction: To respond to the emerging Zika outbreak, a community of practice (CoP) was created to provide support to implement high-quality, coherent research in affected communities in Latin America and the Caribbean (LAC). The achievements of this CoP laid the groundwork for [....] » Read More

Speaker at Infectious Diseases Conferences - Michiel Harmsen
Oral Presentation (In-Person)
Michiel Harmsen, Wageningen University and Research, Netherlands

Unlike most other picornaviruses, foot-and-mouth disease (FMD) intact virions (146S) dissociate easily into small pentameric subunits (12S). This causes a dramatically reduced protective efficacy of vaccines based on authentic FMDV particles. Although this has been observed for d [....] » Read More

Speaker at Infectious Diseases Conferences - Kurt E. Muller
Oral Presentation (In-Person)
Kurt E. Muller, Dresden International University, Germany

Most human functional systems are dual organized, with a supporting and a controlling system that maintains the balance of both through feedback mechanisms. In the case of illness, dysregulation is a temporarily  necessary process that should end with the restauration of bal [....] » Read More

Speaker at Infectious Diseases Conferences - Fawzy Abdelatty
Oral Presentation (In-Person)
Fawzy Abdelatty, Heidelberger Center for Cellular Therapy, Germany

FawCells are Methylation Induced Pluripotent Cells which are prepared from peripheral blood samples. For patients, these samples can be obtained from autologous, heterologous or xenographic sources. These cells are very potent in infection prevention and control. They have the po [....] » Read More

Speaker at Infection Conferences - Goutham Krishna T.C
Oral Presentation (In-Person)
Goutham Krishna T.C, Government Medical College, India

Background: Leptospirosis, a potentially fatal zoonotic infection, has been on the rise in Kerala, India particularly among individuals involved in water-related occupations and activities. With increasing incidence and mortality rates, there is an urgent need to identify key ris [....] » Read More

Speaker at Infectious Diseases Conferences - Gaurav Gupta
Oral Presentation (In-Person)
Gaurav Gupta, AIIMS, India

Aim: to characterize Th1/Th2/Th17 cytokine profile (IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-?, and IL-17A) among different stages of COVID-19 infection. Methods: This was a cross-sectional study which included 6 healthy individuals and 68 patients who were admitted with COVI [....] » Read More

Speaker at Infectious Diseases Conferences - Aishwarya Vyas
Oral Presentation (In-Person)
Aishwarya Vyas, SMS Medical College, India

Purpose: To evaluate the spectrum of coagulopathy in acute sepsis and to correlate it with sequential physiological scores (SOFA & APACHE II) and compare the findings among survivors and non-survivors.  Design: Prospective cohort   Methods: It is a prospective [....] » Read More

Speaker at Infectious Diseases Conferences - Arya S Kumar
Oral Presentation (In-Person)
Arya S Kumar, Amrita Institute of Medical Sciences & Research Centre, India

Introduction: Infection Prevention and Control (IPC) is crucial in healthcare settings, particularly in light of the COVID-19 pandemic. This study aimed to enhance IPC practices across various healthcare facilities in Kerala, India, marking the first multicenter initiative of its [....] » Read More

Speaker at Infection Conferences - Cheung Yuk Yam
Oral Presentation (In-Person)
Cheung Yuk Yam, Hong Kong Metropolitan University, Hong Kong

The emergence of antifungal resistance in Candida species presents significant challenges in managing infections, particularly among immunocompromised patients. This study aimed to develop rapid molecular assays for detecting mutations in the FKS genes across four clinically sign [....] » Read More

Speaker at Infection Conferences - Kyrtania Pather
Oral Presentation (In-Person)
Kyrtania Pather, University of the Witwatersrand, South Africa

Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a significant public health concern globally. Characterized by persistent symptoms such as fatigue, chronic inflammation, and immune dysregulation, Long COVID is believed to increase the risk of non [....] » Read More

Speaker at Infection Conferences - Abraham P. Bayan
Oral Presentation (In-Person)
Abraham P. Bayan, Capitol Medical Center, Philippines

Background: This case report aims to present the applicability and safety of laparoscopic Heller myotomy with anterior fundoplication in an elderly male patient with achalasia and coexisting military tuberculosis. Although the exact cause of achalasia has not been determined, the [....] » Read More

Speaker at Infection Conference - Fernanda Scopelliti
Poster Presentation (In-Person)
Fernanda Scopelliti, National Institute for Health, Italy

Tissue damage caused by Schistosoma mansoni infection is primarily due to a granulomatous, T-cell-mediated response to eggs, which ultimately leads to liver fibrosis and portal hypertension. In the early phase of infection, the immune response is dominated by Th1 lymphocytes; how [....] » Read More

Speaker at Infectious Diseases Conferences - Alejandro Carmona Casillas
Poster Presentation (In-Person)
Alejandro Carmona Casillas, University of Puerto Rico, Puerto Rico

Introduction: Progressive Multifocal Leukoencephalopathy (PML) is a relatively rare manifestation of immunosuppressed patients due to medication or diseases such as HIV/AIDS. PML arises from the reactivation of the human polyomavirus, more commonly known as JC virus. Over th [....] » Read More

Speaker at Infection Conferences - Roman Kozlov
Poster Presentation (In-Person)
Roman Kozlov, Smolenks State Medical University, Russian Federation

Background. Biofilm-related infections are most often characterized by low susceptibility to treatment due to the difficulty of antibiotics penetration into the biofilm. This fact repeatedly increases the level of antimicrobial resistance (AMR). In turn, the spread of AMR signifi [....] » Read More

Speaker at Infectious Diseases Conference - Ziying Yang
Poster Presentation (In-Person)
Ziying Yang, Sun Yat-sen University, China

Background: Acute stress disorder (ASD) is commonly observed among individuals who have been infected with COVID-19 (PEIC) and may progress to post-traumatic stress disorder. Following the relaxation of COVID-19 control measures in China during November/December 2022, the infecti [....] » Read More

Speaker at Kevin Cezar A. Estacio - Kevin Cezar A. Estacio
Poster Presentation (In-Person)
Kevin Cezar A. Estacio, Dr. Paulino J. Garcia Memorial Research Medical Center, Philippines

Introduction: Currently, one of the most significant nosocomial pathogens is Klebsiella pneumoniae strains that produce carbapenemase, in fact it is one of the most prevalent carbapenemase genes worldwide. Its rise also become a major global public health concern, and the be [....] » Read More

Speaker at Infection Conferences - Maria Venice Velasco Atienza
Poster Presentation (In-Person)
Maria Venice Velasco Atienza, Philippine Society of Microbiology and Infectious Diseases, Philippines

Background: Disseminated or extrapulmonary histoplasmosis is seen in patients with impaired T- lymphocyte function. As one of the AIDS-defining conditions, the diagnosis of histoplasmosis is an indication to recommend HIV screening and testing. Case: We report a case of a [....] » Read More

Speaker at Infectious Diseases Conference - Karizza Angeles
Poster Presentation (In-Person)
Karizza Angeles, Dr. Paulino J. Garcia Memorial Research Medical Center, Philippines

Introduction: Acute pancreatitis is considered as an uncommon complication of leptospirosis. However, literatures suggested that this condition still occurs among leptospirosis patients.  This study aims to determine the incidence of acute pancreatitis in moderate [....] » Read More

Speaker at Infectious Diseases Conferences - L. Angelique Gene E. Duran
Poster Presentation (In-Person)
L. Angelique Gene E. Duran, Research Institute for Tropical Medicine, Philippines

Background: WHO declared the Mpox outbreak as a public health emergency of international concern twice in 3 years, in July 2022 and August 2024.  To date, the Philippines has reported 15 confirmed cases. We described the demographics, clinical presentations, transmission ris [....] » Read More

Speaker at Infectious Diseases Conference - Balsam Qubais Saeed
Poster Presentation (In-Person)
Balsam Qubais Saeed, University of Sharjah, United Arab Emirates

Antibiotics significantly reducing morbidity and mortality from bacterial infections. The spread of antibiotic-resistant bacteria has become a pressing global health, endangering the effectiveness of our most potent antibiotics. This study investigates the antibacterial efficacy [....] » Read More

Speaker at Infection Conferences - Hyun Ji Woo
Poster Presentation (In-Person)
Hyun Ji Woo, Jeonbuk National University Hospital, Korea, Republic of

Severe Fever with Thrombocytopenia Syndrome (SFTS) is a life-threatening infectious disease for which no standardized treatment has been established. Observational studies have suggested that therapeutic plasma exchange (TPE) may enhance survival outcomes in patients with SFTS. H [....] » Read More

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Keynote Presentation (In-Person)
Ranjan Ramasamy, IDFISH Technology, United States

Changes in temperature, rainfall and humidity due to global warming affect mosquito-borne disease transmission. However, coastal areas are also influenced by the expansion of brackish water mosquito habitats as a result of global warming leading to higher sea levels. Typical fres [....] » Read More

Speaker at Infection Conferences - Stephen Hsu
Keynote Presentation (In-Person)
Stephen Hsu, Augusta University, United States

Hydrophobic molecules with poor water solubility are often associated with low bioavailability. This physical property prevents these molecules from being developed for new drug use. Examples of these hydrophobic drug candidates include paclitaxel (Taxol), quercetin, cannabidiol [....] » Read More

Speaker at Infectious Diseases Conferences - Arya S Kumar
Oral Presentation (In-Person)
Arya S Kumar, Amrita Institute of Medical Sciences & Research Centre, India

Introduction: Surgical Site Infections (SSI) are a significant healthcare concern, particularly in patients undergoing clean Lower Segment Caesarean Section (LSCS) surgeries. SSIs can lead to severe complications, extended hospital stays, and increased healthcare costs. Object [....] » Read More

Speaker at Infectious Diseases Conferences - Aneesh E M
Oral Presentation (In-Person)
Aneesh E M, University of Calicut, India

Kyasanur Forest Disease (KFD), a viral tick-borne infection, has been a significant public health threat in southern India, particularly in regions with abundant wildlife and forest areas. The disease, primarily transmitted by the bite of infected Haemaphysalis ticks, has been sp [....] » Read More

Speaker at Infection Conference - Garima Joshi
Oral Presentation (In-Person)
Garima Joshi, Regional Center for Biotechnology, India

Our recent study elucidates the protective role of alpha-ketoglutarate (αKG) in suppressing thrombosis and inflammation in mice. This effect is mediated through augmentation of prolyl hydroxylase 2 (PHD2) activity, leading to inhibition of AKT phosphorylation and HIF1-&alph [....] » Read More

Speaker at Infectious Diseases Conference - Vaishnavi V Kudva
Oral Presentation (In-Person)
Vaishnavi V Kudva, K S Hegde Medical Academy, India

The global rise in antibiotic-resistant bacteria, particularly extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae, represents a significant public health concern. This study investigated the prevalence and molecular characterization o [....] » Read More

Speaker at Infectious Diseases Conference - Siwimol Phoomniyom
Oral Presentation (In-Person)
Siwimol Phoomniyom, The Office of Disease Prevention and Control Region 11, Thailand

Virologic-immunologic failure and virologic-immunologic discordance are vital for predicting clinical outcomes. In HIV-infected people, the CD4+ T lymphocyte count (CD4) and HIV viral load were used to track and assess the treatment response of antiretroviral therapy (ART). The o [....] » Read More

Speaker at Infectious Diseases Conference - Helikumi Mlyashimbi
Oral Presentation (In-Person)
Helikumi Mlyashimbi, Mbeya University of Science and Technology, Tanzania, United Republic of

In this research work, we formulated a fractional-order model for the transmission dynamics of Zika virus that incorporates three control strategies namely; health education campaign, use of insecticides, and prevention measures. We presented the theoretical analysis of the model [....] » Read More

Speaker at Infectious Diseases Conferences - Mahmoud Mehranian
Oral Presentation (In-Person)
Mahmoud Mehranian, National University of Skills, Iran (Islamic Republic of)

The cuticle composition of insects contains chitin in a matrix with cuticular proteins, waxes, hydrocarbons, and other compounds. Insect cuticular hydrocarbons (CHCs) are a group of lipids that includes several hundreds of individual compounds among which the main chemical groups [....] » Read More

Speaker at Infection Conferences - James Kinoti Njue
Oral Presentation (In-Person)
James Kinoti Njue, Moi University, Kenya

Background: Human papillomavirus (HPV) causes over 99% of all cervical cancer globally. In 2022, it was responsible for over 3200 deaths in Kenya. Data on the epidemiological distribution of HPV genotypes by cervical dysplasia and HIV status which is important in designing preven [....] » Read More

Speaker at Infection Conferences - Charles Kwobah
Oral Presentation (In-Person)
Charles Kwobah, Moi University, Kenya

Background: Meningo-encephalitis in Sub-Saharan Africa is accompanied by a mortality rate documented as high as 90%. It is linked to diverse immunosuppressive states. The etiology has remained largely undefined by traditional diagnostic tools with studies reporting an unidentifia [....] » Read More

Speaker at Infection Conferences - Larry Afundi Jackson
Oral Presentation (In-Person)
Larry Afundi Jackson, Kenya Medical Research Institute, Kenya

Background: The emergence of antifungal resistance in fungal pathogens highlights the need for local epidemiological data to guide empirical therapy in clinical settings. Fungal research and anti-fungal drug resistance studies are limited in developing countries; hence, there is [....] » Read More

Speaker at Infectious Diseases Conferences - Bhimsingh Bohara
Oral Presentation (In-Person)
Bhimsingh Bohara, BlueCrest University College, Liberia

Infectious diseases continue to pose a major global health threat, made worse by the continuous emergence of new pathogens, especially viruses, and the increasing spread of antibiotic-resistant strains. Viral infections, in particular, are a serious concern due to their ability t [....] » Read More

Speaker at Infection Conferences - Maurice Mbah
Oral Presentation (In-Person)
Maurice Mbah, University of Calabar, Nigeria

The genetic diversity and allele frequencies of MSP-1, MSP-2 and glutamtew rich protein of P. falciparum and consequence on malaria control was investigated in some parts of Cross River State, Nigeria. A total of 230 finger prick samples of blood were examined for the presence of [....] » Read More

Speaker at Infectious Diseases Conference - Harshini
Poster Presentation (In-Person)
Harshini, University of Louisville School of Medicine, United States

Fournier’s Gangrene is an aggressive form of genital necrotizing fasciitis with a mortality rate of 22% – 40%. Clinical features include pain out of proportion to area of erythema, fever, edema, and significant skin discoloration. While traditionally associated with s [....] » Read More

Speaker at Infectious Diseases Conference - Kouki Shinohara
Poster Presentation (In-Person)
Kouki Shinohara, Institute of Science Tokyo, Japan

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has not yet been eradicated. SARS-CoV-2 has two types of proteases, a main protease (Mpro) and a papain-like protease (PLpro). Papain-like protease (PLpro) is a viral p [....] » Read More

Speaker at Infection Conferences - Wooseong Jeong
Poster Presentation (In-Person)
Wooseong Jeong, Jeju National University Hospital, Korea, Republic of

Background: Severe fever with thrombocytopenia syndrome (SFTS) is a zoonotic infectious disease prevalent in East Asia, with a mortality rate of 5–30%. Despite trials with therapeutic plasma exchange (TPE) and antiviral treatments, no established treatment strategy exists f [....] » Read More

Speaker at Infectious Diseases Conference - Jeong Rae Yoo
Poster Presentation (In-Person)
Jeong Rae Yoo, Jeju National University Hospital, Korea, Republic of

Background: Severe Fever with Thrombocytopenia Syndrome (SFTS) is a viral tick-borne disease with high mortality rates, particularly in East Asia. Despite advances in understanding its pathophysiology, effective treatment strategies remain limited. The Multiple Organ Dysfunction [....] » Read More

Speaker at Infection Conference - Xu Wang
Poster Presentation (In-Person)
Xu Wang, Sun Yat-sen University, China

Background: Hepatitis B virus (HBV) infection poses a substantial public health challenge, yet the economic burden of non-hepatic non-communicable diseases (NHNCDs) caused by HBV remains unquantified. We aim to quantify macroeconomic losses of NHNCDs attributable to HBV on a glob [....] » Read More

Speaker at Infection Conferences - Nikrish S Hegde
Poster Presentation (In-Person)
Nikrish S Hegde, Indian Radiological and Imaging Association, India

Acute invasive fungal sinusitis though uncommonly encountered, is a life threatening condition with a high mortality rate. It progresses rapidly from the time of diagnosis and may result in death in a short span of time if left untreated. Here we present the MRI / CT imaging find [....] » Read More

Speaker at Infectious Diseases Conferences - Meryl Louise Su
Poster Presentation (In-Person)
Meryl Louise Su, Cardinal Santos Medical Center, Philippines

Background: To examine the COVID-19 vaccination hesitancy level and influencing factors among parents of children aged 5–17 years residing in San Juan City. Results determined parental concerns and identified effective measures for health education. Objectives: To determ [....] » Read More

Speaker at Infection Conferences - Barbara Cariza Buenafe
Poster Presentation (In-Person)
Barbara Cariza Buenafe, Research Institute of Tropical Medicine, Philippines

Background: Snakebite envenoming has been recognized by the World Health Organization (WHO) as one of the highest priority neglected tropical diseases. Globally, snakebite results in a significant burden of illness, including the Philippines. Snake venom is composed of various to [....] » Read More

Speaker at Infectious Diseases Conferences - Alebel Yaregal Desale
Poster Presentation (In-Person)
Alebel Yaregal Desale, Clinton Health Access Initiative, Ethiopia

Statement of the Problem: Pneumonia is the leading infectious cause of death in children worldwide, accounting for 15% of all deaths in children under the age of five. Hypoxemia is a major cause of death in patients suffering from pneumonia. There is strong evidence that using pu [....] » Read More

Speaker at Infectious Diseases Conference - Oscar Kamasongo
Poster Presentation (In-Person)
Oscar Kamasongo, The University of Zambia, Zambia

Contagious bovine pleuropneumonia (CBPP) is a highly contagious and severe infectious disease of cattle that is listed as a notifiable disease of cattle by the World Organisation for Animal Health (WOAH), which can lead to severe losses of cattle. Recently in the year 2022, two d [....] » Read More

Speaker at Infection Conference - Festus Mulakoli
Poster Presentation (In-Person)
Festus Mulakoli, Aga Khan University, Kenya

Background: Infection with the Dengue virus (DENV) among blood donors presents a significant risk to blood safety and can lead to transfusion-transmitted dengue. Studies conducted in various regions have reported varying prevalence rates of DENV markers among blood donors. Higher [....] » Read More

Speaker at Infectious Diseases Conference - Tapan Parikh
Poster Presentation (In-Person)
Tapan Parikh, Oxford NHS Foundation Trust, United Kingdom

Introduction: This case report describes the presentation, investigation, and non-surgical management of an unusual case of unilateral necrotising cervical lymphadenitis. A two-year-old girl had a three-month history of left-sided submandibular swelling which was managed by her l [....] » Read More

Speaker at Infection Conference - Trisha Marisse F. Montalbo
Poster Presentation (In-Person)
Trisha Marisse F. Montalbo, Research Institute for Tropical Medicine, Philippines

Background: Toxoplasma encephalitis represents a prevalent late-stage complication of severe immunodeficiency in patients living with HIV. Within resource-constrained settings in the Philippines, Trimethoprim-Sulfamethoxazole is the sole available therapeutic intervention for thi [....] » Read More

Speaker at Infectious Diseases Conference - Emiliana Lucas Myovela
Poster Presentation (In-Person)
Emiliana Lucas Myovela, Sokoine University of Agriculture, Tanzania, United Republic of

Introduction: Influenza is a significant global public health threat whose epidemiology is well-documented in high-income countries, whereas data from the African continent, including Tanzania, is still limited. This study was conducted to assess the knowledge, attitude, and prac [....] » Read More

Speaker at Infectious Diseases Conferences - David Martyn Lloyd-jones
Poster Presentation (In-Person)
David Martyn Lloyd-jones, Alfred Health, Australia

The Inclusion Health Program was set up to develop a model of care for people who inject drugs and who have developed acute infections. The aim of the program is to improve both the patient and the healthcare provider experiences by improving healthcare outcomes (treatment comple [....] » Read More

Speaker at Infectious Diseases Conferences - Succes Bouangui-Bazolana
Poster Presentation (In-Person)
Succes Bouangui-Bazolana, University of the Witwatersrand, South Africa

Introduction: Surgical site infection is common in gynaecological oncology surgery worldwide. It constitutes a burden to patients and to the healthcare system. The COVID-19 pandemic resulted in a lockdown across the globe to minimise human contact, therefore curbing the spread of [....] » Read More

Speaker at Infectious Diseases Conferences - Ahad Al Balushi
Poster Presentation (In-Person)
Ahad Al Balushi, Oman Medical Specialty Board, Oman

Background: Brucellosis is a zoonotic disease with a significant impact on Middle Eastern countries, including Oman. Its diagnosis is challenging due to non-specific symptoms and difficulty in interpreting serological test results. This study aims to understand the epidemiology a [....] » Read More

Speaker at Infection Conferences - Reza Nassiri
Keynote Presentation (Virtual)
Reza Nassiri, Michigan State University, United States

Treatment of infectious diseases with antibiotics is a marvel of medicine and the most significant clinical developments of the 21st century. However, the rapid spread of antibiotic resistance genes especially in gran-negative bacteria in the healthcare settings, community, [....] » Read More

Speaker at Infection Conferences - Seki Masafumi
Keynote Presentation (Virtual)
Seki Masafumi, Saitama Medical University International Medical Center, Japan

Background: Respiratory syncytial virus (RSV) is a pathogenic respiratory virus that is considered to affect not only children but also adults, especially elderly persons aged ≥65 years. However, in Japan, the annual epidemic situation and severity of RSV infections in these a [....] » Read More

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
Oral Presentation (In-Person)
Pedro Plans Rubio, College of Physicians of Barcelona, Spain

COVID-19 vaccines have reduced the negative health and economic impact of the COVID.19 pandemic by preventing severe disease, hospitalizations and deaths. In the new socio-economic normality, the COVID-19 vaccination strategy can be universal or high-risk and seasonal or not seas [....] » Read More

Speaker at Infection Conferences - Shree Govani
Oral Presentation (Virtual)
Shree Govani, Kansas City University College of Osteopathic Medicine, United States

Human herpesvirus 6 (HHV-6) is a common virus usually associated with roseola in children. However, reactivation in immunocompetent adults is particularly rare. This, however, can cause diagnostic challenges, which delays the identification and treatment. When HHV-6 reactivates i [....] » Read More

Speaker at Infection Conferences - Furkan Torun
Oral Presentation (Virtual)
Furkan Torun, Ege University, Turkey

Objective: Vaccines are the most cost-effective public health tools for preventing infectious diseases and disease-related disabilities and deaths. Millions of children are saved every year through vaccination. However, increasing the rate of success through more vaccination is p [....] » Read More

Speaker at Infection Conferences - Ndifontiayong Adamu Ndongho
Oral Presentation (Virtual)
Ndifontiayong Adamu Ndongho, Dschang University, Cameroon

Hepatitis B (HBV) and C (HCV) are two among other forms of infections for which co-infection in HIV has been associated with alteration of the immune response, increased risk of progression to liver diseases and increased risk of hepatotoxicity associated to antiretroviral therap [....] » Read More

Speaker at Infectious Diseases Conferences - Antonella Cardone
Oral Presentation (Virtual)
Antonella Cardone, Cancer Patients Europe, Belgium

Background: The decline in global COVID-19 testing has reduced attention to public health measures designed to mitigate infections among vulnerable populations at heightened risk of severe outcomes and long-term complications. With a lack of current guidance and misinformation ar [....] » Read More

Speaker at Infectious Diseases Conferences - Shalini Pooransingh
Oral Presentation (Virtual)
Shalini Pooransingh, The University of the West Indies, Trinidad and Tobago

Objectives: The objective of this study was to describe the epidemiology of malaria in Trinidad and Tobago from 1997 to 2019 and to make recommendations for prevention and control on a background of migration and climate change. Study design: A retrospective review of surveill [....] » Read More

Speaker at Infectious Diseases Conference - Mridula Singh
Oral Presentation (Virtual)
Mridula Singh, Institute of Human Behaviour and Allied Sciences, India

Meningoencephalitis is a significant global burden of morbidity, mortality, and lasting neurological damage, with various causes including viral, non-viral infections, and autoimmune processes. In the West, autoimmune encephalitis has become more common than any individual infect [....] » Read More

Speaker at Infection Conferences - Seema Nabil Nimer
Oral Presentation (Virtual)
Seema Nabil Nimer, University of Jordan, Jordan

SARS-CoV-2 is a virus that affects the human immune system. It was observed to be on the rise since the beginning of 2020 and turned into a life-threatening pandemic. Scientists have tried to develop a possible preventive and therapeutic drug against severe acute respiratory synd [....] » Read More

Speaker at Infection Conference - Orkun Kaymaz
Oral Presentation (Virtual)
Orkun Kaymaz, North Middlesex University Hospital, United Kingdom

Background: Ocular leptospirosis, a severe yet underrecognized complication of systemic leptospirosis, is an emerging global health concern. Primarily affecting tropical and subtropical regions, this neglected zoonotic disease contributes to significant morbidity and vision loss, [....] » Read More

Speaker at Infectious Diseases Conferences - Lidia Sierpinska
Oral Presentation (Virtual)
Lidia Sierpinska, Military Clinical Hospital No.1 with Polyclinic, Independent Public Health Care Unit; Radom Higher School, Radom; Vincent Pol University, Poland

Introduction. Infection with hepatitis C virus (hepatitis C) is an important medical and social problem in Poland and worldwide. In Poland, approximately 2% of the total population is infected with hepatitis C virus (HCV) (estimated at 730,000 people). HCV is an etiologic factor [....] » Read More

Speaker at Infection Conferences - Debra Hawkins
Poster Presentation (Virtual)
Debra Hawkins, University of Oklahoma, United States

This quality improvement (QI) project aims to enhance sepsis management in a rural hospital system facing challenges due to limited resources and lack of specialized training. Sepsis, a critical global health issue, poses unique challenges in rural settings where timely identific [....] » Read More

Speaker at Infection Conferences - Alejandro Amado Baez
Poster Presentation (Virtual)
Alejandro Amado Baez, VA Augusta Health Care System, United States

Background: Septic shock, a severe manifestation of sepsis, is characterized by life-threatening circulatory and metabolic abnormalities, leading to organ dysfunction. Despite global efforts to standardize sepsis management, septic shock remains a significant contributor to [....] » Read More

Speaker at Infectious Diseases Conferences - Anniella Vashti
Poster Presentation (Virtual)
Anniella Vashti, University of Wollongong, Australia

Background: Bloodstream infections (BSI) carry substantial morbidity and mortality, requiring prompt antimicrobial administration. Many global infectious disease and sepsis guidelines suggest a multi-site sampling strategy of blood cultures to diagnose BSI, however, a growing bod [....] » Read More

Speaker at Infection Conference - Karthick Raman
Poster Presentation (Virtual)
Karthick Raman, Sri Ramakrishna Hospital, India

Achromobacter xylosoxidans, formerly called Alcaligenes xylosoxidans, is an oxidase-positive, non-fermentative bacilli primarily found in contaminated soil or water. Irrespective of the age group, it primarily causes opportunistic infections in certain conditions and hospital-acq [....] » Read More

Speaker at Infection Conferences - Jasmine Buck
Poster Presentation (Virtual)
Jasmine Buck, Frimley Health NHS Foundation Trust, United Kingdom

Sepsis has high morbidity and mortality, and continues to be a focus of innovation and improvement internationally. Blood cultures are the single most important microbiological diagnostic tool in the septic patient.  Recent guidance produced by NHS England has highlighted th [....] » Read More

Speaker at Infectious Diseases Conferences - Meerab Fatima
Poster Presentation (Virtual)
Meerab Fatima, Frimley Park hospital, United Kingdom

We present a case of 34 y old male who initially presented to emergency department with multiple episodes of vomiting and diarrhoea accompanied by lower urinary tract symptoms. There was no history of binge alcohol intake, eating takeaway food or travel. On review of his observat [....] » Read More

Speaker at Infection Conferences - Shanees Nazeer
Poster Presentation (Virtual)
Shanees Nazeer, Oxford University Hospitals NHS Foundation Trust, United Kingdom

Background: Community-acquired pneumonia (CAP) accounts for over 100,000 hospital admissions a year in the United Kingdom (UK). There is a need for a standardisation of the diagnosis and management of CAP, further highlighted by the variation in the number and length of CAP admis [....] » Read More

Watsapp